Phase II Study to Evaluate the Efficacy of AMG 317
NCT00436670
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
294
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
BIOLOGICAL:
AMG 317 75 mg
BIOLOGICAL:
AMG 317 150 mg
BIOLOGICAL:
AMG 317 300 mg
BIOLOGICAL:
Placebo
Sponsor
Amgen